HCR 134 Hawaii House · 2026 Regular Session

URGING THE HAWAII STATE DIRECTOR OF HEALTH TO ISSUE A STATEWIDE ORDER TO ALLOW FOR THE SALE AND PURCHASE OF NEBULIZED BUDESONIDE WITHOUT A PRESCRIPTION OR CONSULTATION WITH A HEALTHCARE PROVIDER.

This bill is a non-binding resolution that urges Hawaii's State Director of Health to allow nebulized budesonide and nebulizer machines to be sold without a prescription. It cites international studies and health guidelines suggesting the medication can help treat respiratory conditions like COVID-19. The resolution requests that pharmacies and retailers provide written usage instructions to customers, but it does not change any laws or regulations. The bill does not require the Director of Health to take any action and has no legal effect beyond making a formal recommendation.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2026
Committee Review
Floor Vote
Governor
Introduced Mar 16, 2026 Last action Mar 18, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Mar 18, 2026
Committee
Referred to HLT, CPC, referral sheet 19
lower
Mar 16, 2026
Introduced
Offered
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of David Alcos
David Alcos
RRepublican
HI
41